Pathological complete response and sphincter-sparing surgery after neoadjuvant radiochemotherapy with regional hyperthermia for locally advanced rectal cancer compared with radiochemotherapy alone

Wait-and-See Policy for Clinical Complete Responders After Chemoradiation for Rectal Cancer

(2011) Monique Maas et al.   JOURNAL OF CLINICAL ONCOLOGY

Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial

(2011) Carlo Aschele et al.   JOURNAL OF CLINICAL ONCOLOGY

Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study

(2011) Vaneja Velenik et al.   Radiation Oncology

Preoperative treatment with capecitabine, bevacizumab and radiotherapy for primary locally advanced rectal cancer – A two stage phase II clinical trial

(2011) Gudrun Resch et al.   RADIOTHERAPY AND ONCOLOGY

Regional hyperthermia added to intensified preoperative chemo-radiation in locally advanced adenocarcinoma of middle and lower rectum

(2010) Sergio Maluta et al.   INTERNATIONAL JOURNAL OF HYPERTHERMIA

Comparison of Two Neoadjuvant Chemoradiotherapy Regimens for Locally Advanced Rectal Cancer: Results of the Phase III Trial ACCORD 12/0405-Prodige 2

(2010) Jean-Pierre Gérard et al.   JOURNAL OF CLINICAL ONCOLOGY

Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data

(2010) Monique Maas et al.   LANCET ONCOLOGY

A phase II study of cetuximab, capecitabine and radiotherapy in neoadjuvant treatment of patients with locally advanced resectable rectal cancer

(2009) V. Velenik et al.   EJSO

The 5×5Gy with delayed surgery in non-resectable rectal cancer: A new treatment option

(2008) Krzysztof Bujko et al.   RADIOTHERAPY AND ONCOLOGY